Usage of nutrient Medium Based on Dry Hydrolysate of Casein in Manufacturing Bivalent Chemical Cholera Vaccine
https://doi.org/10.21055/0370-1069-2019-4-26-30
Abstract
Objective of the study was to select the standardized substrate containing dry hydrolysate of casein for preparation of nutrient medium utilized for manufacturing bivalent chemical cholera vaccine under submerged cultivation of cholera vibrio strains in fermenters. Materials and methods. We used Vibrio cholerae O1 strains of classical biovar: strain 569B Inaba and strain M-41 Ogawa. Examined were two dry substrates of the medium: enzymatic hydrolysate of casein, Type I Himedia (India) and pancreatic hydrolysate of casein, produced by the State Scientific Center of Applied Microbiology and Biotechnology (Russian Federation). Produced under laboratory conditions at the premises of the RusRAPI “Microbe” medium was used as a control. Submerged cultivation was conducted in bioreactors during (9±1) h with aeration and automatic feeding of glucose and ammonia. Production of protective antigens was measured applying immunochemical and biological methods. Results and discussion. It is demonstrated that submerged cultivation of cholera vibrio production strains on nutrient media under study provides for synthesis of protective antigens the parameters of which comply with the requirements of normative documentation. More standardized and higher indicator values of the target product are ensured by cultivation of producer strains on nutrient medium with a substrate from dry enzymatic hydrolysate of casein, containing (1.5±0.1) g/l of amino nitrogen for the strain V. cholerae M-41 and (2±0.1) g/l – for V. cholerae 569 B. Transition to the use of standardized dry protein components of cultivation media does not lower the quality of the chemical cholera vaccine, but allows for the reduction of cost price and duration of technological process.
About the Authors
N. I. BelyakovaRussian Federation
Nina I. Belyakova.
46, Universitetskaya St., Saratov, 410005.
L. F. Livanova
Russian Federation
46, Universitetskaya St., Saratov, 410005.
O. V. Gromova
Russian Federation
46, Universitetskaya St., Saratov, 410005.
O. S. Durakova
Russian Federation
46, Universitetskaya St., Saratov, 410005.
O. D. Klokova
Russian Federation
46, Universitetskaya St., Saratov, 410005.
K. I. Kholmatov
Russian Federation
46, Universitetskaya St., Saratov, 410005.
M. V. Antonycheva
Russian Federation
46, Universitetskaya St., Saratov, 410005.
Z. L. Devdariani
Russian Federation
46, Universitetskaya St., Saratov, 410005.
O. A. Volokh
Russian Federation
46, Universitetskaya St., Saratov, 410005.
References
1. Ali M., Nelson A.R., Lopez A.L., Sack D.A. Updated global burden of cholera in endemic countries. PloSNegl. Trop. Dis. 2015; 9(6):e0003832. DOI: 10.1371/journal.pntd.0003832.
2. World Health Organization. Cholera, 2015. Wkly. Epidemiol. Rec. 2016; 91(38):433–40.
3. World Health Organization. Cholera. 2017. Wkly. Epidemiol. Rec. 2018; 93(38):489–500.
4. Goryaev A.A., Sayapina L.V., Obukhov Yu.I., Bondarev V.P. [Efficiency and safety of the vaccines for cholera prophylaxis]. BIOpreparaty. Profilaktika, Diagnostika, Lechenie [BIOpreparations. Prophylaxis, Diagnostics, Treatment]. 2018; 18(1):42–9. DOI: 10.30895/2221-996X-2018-18-1-42-49.
5. State Pharmacopeia of the Russian Federation, XIV edition. Moscow; 2018. Vol. 1–4.
6. Anisimov P.I., Adamov A.K., Dzhaparidze M.N., Naumov A.V., Nikitina G.P. [Method for the production of the vaccine for cholera prophylaxis]. RF Patent No 2080121, published on May 27, 1997.
7. Dzhaparidze M.N., Naumov A.V., Nikitina G.V. [Oral chemical vaccines from hyper-toxigenic strains KM76 Inaba and KM68 Ogawa of cholera agent]. Zhural Mikrobiologii, Epidemiologii, Immunobiologii [Journal of Microbiology, Epidemiology, and Immunobiology]. 1991; 68(4):31–6.
8. Onishchenko G.G., Kutyrev V.V., Shchukovskaya T.N., Smirnova N.I., Nikiforov A.K., Eremin S.A., Toporkov V.P. [Cholera Specific Prophylaxis in Modern Conditions]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2011; 1:5–12. DOI: 10.21055/0370-1069-2011-1(107)-5-12.
9. Eremin S.A., Aleshina Yu.A., Komissarov A.V., Gromova O.V., Vasin Yu.G., Nikiforov A.K., Livanova L.F., Volokh O.A., Lobovikova O.A., Bronnikova V.S. [Methods and technologies of cholera vibrio cultivation (Scientific Review)]. Problemy Osobo Opasnykh Infektsii [Problems of Particularly Dangerous Infections]. 2013; 4:95–101. DOI: 10.21055/0370-1069-2013-4-95-101.
10. Eremin S.A., Komissarov A.V., Livanova L.F., Belyakova N.I., Volokh O.A., Vasin Yu.G., Nikiforov A.K. [Effectiveness enhancement of cultivation of Vibrio cholerae production strains – producers of protective antigens, in the process of manufacturing of tableted chemical cholera vaccine]. In: [Cholera and Pathogenic for Humans Vibrios]. Rostov-on-Don; 2013. P. 241–3.
11. Shaginyan I.A., Marakusha B.M. [Modification of passive immune hemolysis on solid medium for detection of thermo labile enterotoxin production by cholera vibrio and colibacillus strains]. Zhurnal Mikrobiologii, Epidemiologii, Immunobiologii. [Journal of Microbiology, Epidemiology, and Immunobiology]. 1983; 60(2):92–6.
12. Craig J.P., Yamamoto к., TakedaY., Miwatani T. Production of cholera-like toxin by V. cholerae non-O1 strains isolated from environment. Infect. Immun. 1981; 34(1):90–7. PMID: 7298194. PMCID: PMC350825.
Review
For citations:
Belyakova N.I., Livanova L.F., Gromova O.V., Durakova O.S., Klokova O.D., Kholmatov K.I., Antonycheva M.V., Devdariani Z.L., Volokh O.A. Usage of nutrient Medium Based on Dry Hydrolysate of Casein in Manufacturing Bivalent Chemical Cholera Vaccine. Problems of Particularly Dangerous Infections. 2019;(4):26-30. (In Russ.) https://doi.org/10.21055/0370-1069-2019-4-26-30